ExpreS2ion Biotech
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar! Pareto and Analysguiden publish research reports
The Analysguiden report dives deeper into recent topics related to the COVID-19 vaccine, including upcoming milestones, the 26 January 2023 FDA advisory committee meeting, Bavarian Nordic’s expected payments to ExpreS2ion associated company and partner in the COVID-19 vaccine, AdaptVac, and vaccination trends. Furthermore, Analyst Sten Westerberg comments on the rights issue, recently formed infectious diseases advisory board, and recently announced mucosal vaccine program.
The research reports are available on the Analyst Reports page of ExpreS2ion’s investor website.
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
| Datum | 2023-03-16, kl 18:00 |
| Källa | Cision |